- Forums
- ASX - By Stock
- NUZ
- Ann: Phase II trial prelim results demonstrate clinical benefit
Ann: Phase II trial prelim results demonstrate clinical benefit, page-30
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $93.42M |
Open | High | Low | Value | Volume |
19.0¢ | 19.5¢ | 19.0¢ | $41.04K | 216.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 36359 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 19561 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 36359 | 0.190 |
16 | 854962 | 0.185 |
8 | 336753 | 0.180 |
4 | 120797 | 0.175 |
5 | 159661 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 19561 | 2 |
0.200 | 114894 | 6 |
0.205 | 109808 | 2 |
0.210 | 107676 | 2 |
0.215 | 100000 | 1 |
Last trade - 12.34pm 13/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online